John is a 58-year-old male brought to the emergency department after an out-of-hospital cardiac arrest. During advanced cardiac life support, invasive arterial blood pressure monitoring is established. He receives epinephrine as per ACLS protocol. His initial diastolic blood pressure (DBP) is 25 mmHg, and 3 minutes after epinephrine administration, his DBP increases to 40 mmHg.

Based on recent evidence, how should the pharmacist interpret the significance of John’s increase in diastolic blood pressure following epinephrine administration during resuscitation?

Emily, a 65-year-old female with no significant past medical history, is undergoing resuscitation for out-of-hospital cardiac arrest in the emergency department. The code team administers epinephrine every 3-5 minutes as per guidelines. The pharmacist is monitoring invasive arterial blood pressure readings in real time and notes minimal change in mean arterial pressure (MAP) after epinephrine doses.

What is the most appropriate pharmacist recommendation based on the observed minimal MAP increase after epinephrine administration?

Michael, a 72-year-old male with hypertension and diabetes, is undergoing CPR for out-of-hospital cardiac arrest. After epinephrine administration, his systolic blood pressure (SBP) increases by 10 mmHg, but diastolic blood pressure (DBP) and mean arterial pressure (MAP) show minimal change. The pharmacist is asked to counsel the code team on the significance of these findings.

Which statement best reflects the clinical significance of Michael’s blood pressure changes post-epinephrine according to recent research?